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Abstract
Brain adaptation to hyposmolarity is accomplished by
loss of both electrolytes and organic osmolytes, including amino acids, polyalcohols and methylamines.
In brain in vivo, the organic osmolytes account for
about 35% of the total solute loss. This review focus
on the role of amino acids in cell volume regulation,
in conditions of sudden hyposmosis, when cells respond by active regulatory volume decrease (RVD)
or after gradual exposure to hyposmotic solutions, a
condition where cell volume remains unchanged,
named isovolumetric regulation (IVR). The amino acid
efflux pathway during RVD is passive and is similar in
many respects to the volume-activated anion pathway. The molecular identity of this pathway is still
unknown, but the anion exchanger and the
phospholemman are good candidates in certain cells.
The activation trigger of the osmosensitive amino acid
pathway is unclear, but intracellular ionic strength
seems to be critically involved. Tyrosine protein kinases markedly influence amino acid efflux during
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RVD and may play an important role in the transduction signaling cascades for osmosensitive amino acid
fluxes. During IVR, amino acids, particularly taurine
are promptly released with an efflux threshold markedly lower than that of K+, emphasizing their contribution (possibly as well as of other organic osmolytes)
vs inorganic ions, in the osmolarity range corresponding to physiopathological conditions. Amino acid efflux
also occurs in response to isosmotic swelling as that
associated with ischemia or trauma. Characterization
of the pathway involved in this type of swelling is hampered by the fact that most osmolyte amino acids are
also neuroactive amino acids and may be released in
response to stimuli concurrent with swelling, such as
depolarization or intracellular Ca++ elevation.
Copyright © 2000 S. Karger AG, Basel

Introduction
Cell volume perturbation is a challenge for
homeostasis in all animal organs, but has particularly
dramatic consequences in brain. The limits to expansion
imposed by the rigid skull give narrow margins for the
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Fig. 1. Contribution of different types
of osmolytes to volume adjustment in
brain in vivo during chronic
hyponatremia. Recalculated from:
Lien et al, 1991; Verbalis and Gullans,
1991, 1993; Lien, 1995; Sterns et al,
1993. Glycero-phosphoryl choline
(GPC), Phosphoetanolamine (PEA),
N-acetylaspartate (NAA), Creatine
(Cr), Phosphocreatine (PCr), Myoinositol (Myo-I) and Amino acids
(AA).

buffering of intracranial volume changes, leading to
compression of small vessels generating episodes of
anoxia and ischemia. As pressure increases, herniation
leads to respiratory and cardiac arrest. Besides these
extreme effects, brain cell swelling may also lead to
hyperexcitability [1]. Early studies in chronic
hyponatremia, showed that brain does not behave as a
perfect osmometer, and the initial swelling is followed
by progressive water loss until almost complete
normalization, despite the persistence of hyponatremia.
The observed electrolyte decrease was not sufficient to
compensate for the loss of water and evidence was then
obtained pointing to a significant contribution of organic
osmolytes, including the most abundant amino acids, as
well as of N-acetylaspartate, myo-inositol, creatine,
phosphocreatine, phosphoetanolamine and glycerophosphoryl choline [2, 3] (Fig. 1). In rodents, taurine is
the most important organic osmolyte, because it is highly
concentrated and shows the largest reduction during
hyponatremia. In other species with lower brain taurine
content, compounds such as N-acetylaspartate, may have
an important role [4]. The estimation of organic osmolyte
change in all these studies does not discriminate neither
the regional variation within the brain nor possible

differences in the cell type. In vitro studies in tissue slices
as well as in cells in culture exposed to hyposmotic media
represent a convenient model to address these questions.
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Amino acids and regulatory volume decrease (RVD) during hyposmosis
Activation and inactivation of corrective fluxes
In cultured astrocytes and neurons, hyposmosis leads
to rapid swelling followed by typical RVD. The efflux
pattern of amino acids closely parallels the time course
of the change in cell volume [5] in contrast to Cl- and K+
fluxes which are faster (Cl-) or slower (K+) than the
change in cell volume. Osmosensitive efflux of amino
acids has also been reported in hippocampal and cortical
slices [6, 7] and in vivo during continuous superfusion
of cerebral cortex [8] or by microdialysis [9]. In all these
preparations, taurine is the most sensitive to the osmotic
perturbation, with the lowest release threshold and the
largest amount released. Interestingly, in the neuroblastoma cell line CHP-100, glutamate is not responsive to
hyposmosis [10].

The amino acid efflux pathway
A leak pathway rather than an energy-dependent
cotransporter, was first suggested as the mechanism for
osmosensitive taurine release in Ehrlich ascites cells [11]
and this was confirmed in brain cells, in which taurine
translocation is passive, directed only by the concentration gradient. [12]. Unexpectedly, taurine efflux was
found sensitive to Cl- channel blockers [5], and this led
to propose an anion channel-like molecule as the transport pathway for Cl- and organic osmolytes [13]. The Clchannel involved in RVD is a volume-sensitive outwardly
rectifying Cl- channel (VSCC) of broad spectrum, permeable to most monovalent anions, and to some extent
to large anions and to organic anions [14-17]. The properties of VSSC have been recently reviewed in detail
[14, 15]. In brain cells, this channel has been characterized in the C6 glioma cell line [13], in cerebellar granule
neurons [17] and in the N2A neuroblastoma [18]. Evidence in support of this VSCC as the common pathway
for organic osmolytes is rather indirect, based essentially
on the similar pharmacological profile of swelling-activated Cl- currents and the swelling-induced osmolyte
release [5, 13]. Currents carried through VSCC by
glutamate, taurine and aspartate in the anion form, have
been observed in MDCK, glioma and IMCD cells [19,
20]. Although these experiments do not prove the transport of neutral amino acids, they at least demonstrate
that the size of the pore is sufficiently large for the passage of amino acids. Against this common pathway are
findings of cell lines exhibiting Cl- channel but not taurine fluxes and vice versa [16]. Also, different actions of
blockers (arachidonic acid and DIDS) suggest different
pathways [21, 22]. Swelling-induced taurine release without chloride channel activity in oocytes expressing anion channels and transporters also strongly favors the
idea of separate pathways for taurine and Cl- [23]. If this
is the case, it should be a remarkable similarity between
the molecular species permeating the two types of
osmolytes, or a close interconnection between the fluxes
of Cl- and organic osmolytes.
Osmosensitive taurine fluxes appear to be carried
by the anion exchanger in fish but not in mice erythrocytes [24, 25]. The protein domains responsible for the
differences between mouse and trout anion exchangers
have been identified, thus opening the possibility to select the anion exchanger forms in different cell types by
the presence of these protein domains [26]. The
phospholemman another canditate for taurine transport
is a member of a superfamily of proteins with single transAmino Acids and Volume Regulation in Brain Cells

membrane domains exhibiting markedly high permeability to taurine, a feature possibly due to the presence of
binding sites for cations and anions within the pore.
Phospholemman is present in cultured astrocytes and
neurons. Overexpression in HEK cells increases RVD,
osmosensitive Cl- currents and taurine fluxes [27, 28].

Activation and transduction signalling cascades
The trigger to activate the osmosensitive Cl-/amino
acid pathways and the identification of transduction signalling cascades are still unresolved. Available information refers mainly to the volume-activated Cl- currents,
with scarce confirmation about similarities or dissimilarities with the amino acid efflux pathways. Hyposmotic
swelling leads to changes in the concentration of second
messengers, such as Ca2+, cAMP, IP3 and arachidonic
acid [29]. It is still undefined whether these signalling
systems are part of the mechanisms directly activating
the osmolyte corrective fluxes or occur in connection
with the set of other cell responses generated by
hyposmosis. Cell swelling and RVD are complex phenomena involving cell reactions to stress, reorganization
of the cytoskeleton, and adhesion or retraction mechanisms, among others. All of them activate their own signals, which may or may not be implicated in the activation of corrective osmolyte fluxes.
Calcium and calmodulin
Hyposmotic swelling is associated with an increase
in [Ca2+]i levels, which occurs also in brain cells. However, with few exceptions, Cl- currents and osmosensitive
taurine fluxes are essentially Ca2+-independent [30], although a minimal amount of cell Ca2+ (>50 nM), referred
as permissive Ca2+, appears necessary for the activation
of Cl-/taurine osmosensitive fluxes [31]. It might thus be
that the swelling-induced [Ca2+]i increase is an epiphenomenon, unrelated to the corrective fluxes of osmolytes.
Taurine fluxes are blocked by pimozide and trifluoperazine [6] but their effects appear unrelated to calmodulin
systems since the inhibition persists in cells where taurine efflux is Ca2+-independent or even in those where
swelling does not elicit any Ca2+ increase.
Protein kinases (PK)
PKC, PKA and cAMP. The osmosensitive amino
acid fluxes appear largely PKC independent, as shown
by the failure of PKC blockers or to maneuvers directed
Cell Physiol Biochem 2000;10:361-370
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to activate or down regulate the enzyme [32]. Taurine
fluxes are PKC-independent in rat supraoptic nucleus
and in cultured cerebellar granule neurons [33, 34].
Swelling- and stress-induced changes in cAMP levels
have been reported in some but not in all cell types [15].
cAMP potentiates osmosensitive taurine efflux in C6
cells and in brain cortex [32, 35], but not in cerebellar
granule neurons nor in supraoptic nucleus slices [33, 34].
Information about modulation of VSCC by protein kinases is reviewed in detail in [14, 15].
Protein tyrosine kinases
A role for protein tyrosine kinases (PTK) in the
volume-related signalling is suggested by the numerous
PTK which phosphorylate by swelling: p125FAK,, p38,
JNK, p56lck, p72syk and ERK1/ERK2 [36-40]. Further
support comes from the potent inhibitory effect of PTK
blockers on Cl- and taurine fluxes and the corresponding
potentiation by the tyrosine phosphatase blocker o-vanadate [34, 36]. The specific kinases involved in amino
acid release and the precise step of reaction have not
been identified. Swelling activation of PTK does not necessarily imply a link with osmolyte fluxes, as occurs for
ERK1/ERK2, for which prevention of the hyposmosisinduced phosphorylation has no effect on taurine fluxes
or Cl- currents [34, 36]. The same lack of correlation is
found for the stress-activated protein kinase p38 [41].
This dissociation suggests the involvement of some PTK
in phenomena coincident with swelling, but not necessarily in the activation of osmosensitive fluxes. However, such correlation may be cell specific, as shown for
ERKs phosphorylation and the osmosensitive Cl- current in cortical astrocytes [37]. Swelling-induced activation of p56lck in lymphocytes is required for VSCC
functioning as p56lck deficiency by genetic knockout,
leads to defective VSCC and RVD, a condition reversed
by retransfection of the protein [39]. Swelling-induced
tyrosine phosphorylation of band 3 (anion exchanger) in
skate erythrocytes is also linked to p72syk and p56lyn [42].
This is the first report showing direct tyrosine phosphorylation of the osmolyte translocation pathway.
Tyrosine kinases and cytoskeleton
Cell swelling and RVD require a substantial reorganization of the cytoskeleton, to cope with the changes
in cell volume and cell adhesion, but it is unclear whether
these changes are directly involved in activation of
osmolyte fluxes. A connection may be established
through p21Rho, which is closely involved in the reor-
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ganization of the actin cytoskeleton and also modulates
osmosensitive Cl- currents [43, 44]. Downstream Rho,
two possibilities have been explored, one of them suggesting a link with p125FAK and PI3 kinase, and another
one proposing Rho kinase as the downstream target [43,
44]. Manipulation of these pathways has clear effects on
VSCC, but less is known about their influence in amino
acid fluxes. A cytoskeleton connection with taurine is
suggested by decreased hyposmotic taurine efflux in astrocytes from vimentin/GFAP-deficient mice as compared to cells from the wild type mice [45].
PI3 kinase
Hyposmosis activates PI3K in some cells, and blockade by wortmannin, LY294002 or antibodies to the 110catalytic subunit impairs cell volume recovery, VSCC
activation, and the osmosensitive I125 and taurine fluxes
[34, 43, 46]. In cerebellar granule neurons, wortmannin
but not LY294002, decreases the osmosensitive taurine
efflux [34]. This difference may be due to permeability
restrictions to LY294002 or to different sensitivity of
PI3K isoforms. However, results based only on effects
of wortmannin should be taken with caution, further considering that wortmannin may also affect phospholipase
A and the myosin light chain, two proteins which also
appear involved in osmolyte fluxes [47].
Phosholipases (PL)
Implication of PLAs in osmolyte fluxes came from
the early work by Hoffman, Lambert and coworkers [48]
in Ehrlich ascites cells, showing an effect of leukotrienes
LTC4 and LTD4 accelerating RVD and enhancing taurine efflux under isotonic conditions. This may not be a
general mechanism of osmolyte activation since LTD4
does not affect the osmosensitive Cl- currents in many
other cell types [14,15]. However, PLA2 may still modulate the taurine/Cl efflux pathways as shown by a study
in neuroblastoma CP100 cells, where swelling increases
arachidonic acid release, which, if prevented by
AACOCF3, inhibits taurine and Cl- fluxes [49]. At variance with these results in isolated cells, in rat brain cortex in vivo, amino acid fluxes are essentially unaffected
by the PLA2 blockers pBPB, DEDA and AACOCF3
[32].
The connection between all these enzymes remains
to be established. PI3K is a key intermediate in signaling cascades, interacting notably with the Rho GTP-binding proteins, which as discussed above, appear to criti-
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cally influence VSCC. An association between PI3K,
Rho GTPases and phospholipases has been shown in a
variety of pathways, some of them regulating the dynamics of the cortical and cytoplasmic actin cytoskeleton. A possibility that cannot be ruled out is that PLA2
is acting at the very early steps of the signalling cascades acting as a volume sensor, since there is some evidence in support of PLA2 as a mechanosensor [50].
The influence of ionic strength
The importance of intracellular ionic strength as a
regulatory signal for activation of taurine fluxes in trout
erythrocytes was first proposed by Motais et al. [51].
Consistent with this proposal are findings in C6 glioma
and in CHO cells showing that, as intracellular ionic
strength increases, larger volume changes are progressively required to activate taurine efflux [52]. In cortical
astrocytes, taurine efflux is notably higher when swelling decreases ionic strength as in hyposmotic- or ureainduced swelling, as compared with K-generated swelling occurring without a decrease in ionic strength [53].
In CPAE cells, a Cl- current identical to that elicited by
hyposmotic swelling is activated by reducing the ionic
strength at constant osmolarity. All these results suggest
an effect of intracellular ionic strength either shifting the
volume set point [52] or directly acting as activation signal [54]. A recent study in skate red blood cells confirms
the above results, but in addition, demonstrate the influence of ionic strength on the activity of some PTK directly involved in the activation of taurine fluxes [55].

Amino acids and isosmotic swelling
Brain cell edema in isosmotic conditions (also called
cytotoxic edema) conveys more risks than hyposmotic
swelling, since in cytotoxic swelling there is no clear
evidence of efficient cell volume correction. Ischemic
stroke, head trauma and hepatic encephalopathy, are
pathological conditions associated with brain edema,
leading to a critical clinical challenge. Swelling also occurs in excitotoxicity and seizures [56]. The mechanisms
generating swelling may be somewhat different in each
pathology, but in all cases, the influx of anions, Cl- or/
and bicarbonate-, is a consistent causal factor.
As mentioned above, in brain cells adaptive mechanisms during isosmotic swelling appear less efficient than
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in hyposmotic swelling. This may have to do with a difficulty for ionic osmolytes to be released when ion accumulation is the condition generating swelling. In this case,
the contribution of organic osmolytes may not be sufficient to regulate cell volume, although it is certainly
important to attenuate the magnitude of swelling. Amino
acid efflux during cytotoxic swelling has been observed
in experimental models of ischemia, from in vitro chemical models or in vivo, by vein occlusion. Cell exposure
to high K+ concentrations, as occurs in most situations
leading to cytotoxic swelling, is often used to generate
cytotoxic edema. Activation of the various excitatory
receptor subtypes by glutamate, kainate and other agonists, are also experimental models simulating cytotoxic
swelling. In all these cases, fluxes of taurine, glutamate,
GABA and glycine, consistently increase. However, it
should be mentioned that these amino acids are all neuroactive compounds, and some of them are important
synaptic transmitters. Therefore, when evaluating the
effect of cytotoxic edema on amino acid release, it is
necessary to discriminate between a pure response to
swelling and that related to other signals, as depolarization or Ca2+ entry, concurrent with ischemia, epileptic
activity or excitotoxicity. Conversely, increase of extracellular K+ or glutamate concentration known to occur
in ischemia or epileptic episodes, and currently attributed to neuronal hyperexcitability, may rather be a response to swelling. This point has been addressed recently in studies about the mechanism of glutamate efflux
in ischemia. Two possibilities have been considered. One
explains the increase in extracellular glutamate concentration as a result of swelling-activated corrective efflux
[56, 57]. The other one implicates a reverse operation of
the energy-dependent glutamate transporters, due to intracellular Na+ accumulation resulting from the energy
failure, and thus, unrelated to swelling. Both possibilities have experimental support, but the option involving
an impaired transport mechanism is more favored at
present [58]. An effect of swelling on glutamate transporters has been described, which may link the two options [56]. The same situation applies for other amino
acids such as aspartate, GABA, taurine and glutamine,
which are also released in ischemic conditions, and are
also transported by energy-dependent carriers [59-61].
Depolarization concurrent with ischemia may also trigger amino acid release. Differences may exist, though,
in the relative sensitivity of amino acids to swelling or
depolarization, which may be useful to estimate their role
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as osmolytes in cytotoxic edema. In any event, the release of inhibitory amino acids such as taurine, GABA
or glycine, which in contrast to glutamate, do not generate per se a secondary volume increase, nor excitotoxicity, may contribute to attenuate swelling and additionally, to counteract the hyperexcitability generated by
K+ and glutamate.
Studies in ischemic models of vein occlusion, have
shown a blockade of amino acid fluxes by anion channel
inhibitors, as in hyposmotic swelling, suggesting similar translocation pathways in the two conditions [61,62].
However, it is worthy to emphasize that these agents affect most Cl- channel types and may affect Cl- influx
which is an essential causal element of swelling. Therefore, a reduced efflux of amino acids may be due, not to
an effect on the efflux pathway, but a consequence of
less swelling by Cl- influx reduction. Cytotoxic swelling
associated with hyperamonemia or with head trauma also
involves an increased efflux of amino acids, including
excitotoxic amino acids. The mechanism of this release
is still unclear, but at least for glutamate and taurine, it
seems not directly related to a swelling-induced efflux
[63]. Lactacidosis is a prominent sequel in ischemic and
traumatic brain tissue resulting in glial cell swelling. The
swelling mechanism involves activation of coupled Na+/
H+ and Cl-/HCO3- antiporters, resulting in intracellular
accumulation of NaCl and water. There is no evidence
for compensatory mechanisms to regulate swelling under these conditions. Also there is as yet only scarce information about activation of osmolyte fluxes associated
with this model of swelling. A microdialysis study on
NH4+ -induced acidosis reports an increase in extracellular N-acetyl-aspartate, an amino acid present in large
amounts in neurons, which may have an important role
as osmolyte [4].
There is scarce information about possible signalling cascades for activation of mechanisms of cell volume control in isosmotic swelling. The work by Phillis,
O’Regan and their collaborators [60] in a model of ischemic rat brain cortex, have shown the influence of PKC
based on the stimulatory effect of phorbol esters and the
inhibition by chelerythrine on glutamate and aspartate
fluxes increased during ischemia. PKA seems not involved in this process. It also documents the importance
of phospholipases, PLC and particularly of PLA2, in this
mechanism of ischemia-induced amino acid efflux [60].
They also suggest an influence of PTK, since the tyrosine
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kinase inhibitor genistein, attenuates neurotransmitter
release from the ischemic rat cerebral cortex [64]. Recently these authors have made a comparison between
the features of amino acid release during ischemia and
during hyposmotic swelling in the rat brain. They found
important differences, particularly regarding the role of
PLA2, which being critical for activation of amino acid
release in ischemia, seems to play a minor role in the
hyposmotic-stimulated release of amino acids in the same
preparation [32]. Also, while PKC modulates ischemiainduced amino acid release, it has no major influence on
the hyposmolarity-associated release [32]. These comparative studies are crucial to identify the signalling elements associated with isosmotic swelling within the complex set of responses evoked by ischemia.
Identification of the transduction cascades in isosmotic swelling may be further complicated by the fact
that essentially all conditions generating this type of
swelling represent severe stressful situations, resulting
in activation of numerous signalling elements associated
with stress [65]. Some of them such as MAPK and PI3K,
are also activated during hyposmotic swelling. The associated events of depolarization and excitotoxicity specific to brain tissue, also activate numerous signalling
cascades [66]. All this makes it very difficult to discriminate among the spectrum of responses, those solely attributable to swelling. An experimental maneuver to circumvent this problem, which could be approached in
preparations in vitro, is to elicit the ischemic or any other
situation of cytotoxic swelling, but reducing the external concentration of Cl-, which would largely attenuate
swelling without decreasing the depolarization or other
stimuli. Then, a parallel analysis of the signalling cascades activated in both conditions, may help to identify
those associated with swelling, and from them, those
related to the corrective fluxes of osmolytes.
It has been consistently observed that cytotoxic
edema in vivo is more prominent in astrocytes than in
neurons, being so far unclear whether this difference is
due to a selective localization of the swelling-generating
mechanisms in astrocytes, or to the presence in neurons
of more efficient mechanisms of cell volume control. In
this respect, a most interesting observation is the transfer of taurine and glutamate from neurons to astrocytes
during experimental ischemia [67]. By this mechanism,
neurons are spared and protected from the deleterious
effects of swelling.
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Isovolumetric regulation: role of amino
acids
Although the experimental model of sudden and
marked decreases in osmolarity has rendered valuable
information to elucidate the basic mechanisms of cell
volume control, such changes probably never occur in
brain under physiological conditions. Even during pathological situations such as chronic hyponatremia, water
intoxication or the inappropriate handling of antidiuretic
hormone, the osmolarity changes in the interstitial space
in brain occur most likely in a gradual manner as the
osmotic challenge from plasma progressively surpasses
the brain homeostatic resistance. A paradigm closer to
the situation in vivo, was that assayed first by Lohr and
Grantham [68] in renal proximal tubules, in which cells
were exposed to small and gradual decreases in osmolarity. Under these conditions, cell volume remains stable
over a broad range of osmolarities, even when the osmolarity drops up to 50%. This constancy in cell volume
was named ”isovolumetric regulation” (IVR). This term
has implicit the idea of an active mechanism of cell adjustment, based on the shrinkage in cells returned to an
isosmotic medium, which due to the loss of intracellular
osmolytes is now hyperosmotic with respect to the intracellular medium [68]. After this early report, IVR has
been observed in the renal cell line A6, in the glioma
cells C6 [69, 70], in cerebellar granule neurons (unpublished), in cardiomyocytes [71] and in a more integrated
preparation, the hippocampal slice [72]. In contrast, partial IVR is found in cardiomyocytes and no IVR is observed in trout erythrocytes [71, 73] . The mechanisms
subserving IVR have not been explored in detail. In A6
cells, increased K+ efflux is observed at 30% reductions
in external osmolarity [68]. K+ efflux with a similar
threshold was found in cultured cerebellar granule neurons (unpublished results) and in cardiomyocytes [71].
K+ efflux during IVR is decreased by Ba2+, but is insensitive to 4AP, TEA and charybdotoxin (unpublished results). The Cl- pathway activated during IVR seems to
have marked differences with the VSCC, as IVR is impaired when Cl- is replaced by other anions which permeate through VSCC [69]. This may suggest the involvement of electroneutral cotransporters, known to be more
selective for anions than VSCC. In hippocampal slices,
IVR occurred without any measurable release of K+ [72].
This is an unexpected finding which may be attributable
to the large K+ buffering capacity of astrocytes. We have

addressed the role of amino acids in IVR in hippocampal slices and found increased fluxes of taurine, GABA
and glutamate (Fig. 2). The efflux of taurine shows the
lowest threshold, and the highest efflux rate with 4-10fold differences at essentially all osmolarities. This may
reflect a higher permeation through the efflux pathway
or/and more availability of the taurine pools to be released in response to the change in cell volume. This
may be related to features of taurine such as its metabolic inercy and its mainly cytoplasmic location, while
GABA, glycine and glutamate, which have a prominent
role as synaptic transmitters or are part of numerous
metabolic cascades, may be sequestered in compartments
which restrict their availability for osmosensitive release.
Taurine efflux during IVR has been shown in cardiac
myocytes and in trout erythrocytes, with reductions of
10-17% in taurine cell content [71, 73].
About 30% in average, of the amino acid content in
cells or slices is released during IVR. This is clearly insufficient to compensate for the change in external osmolarity when K+ fluxes have not yet been activated.
Therefore, other factors should be considered to explain
the maintenance of cell volume under these conditions.
One or several of the following possibilities are plausible: 1) swelling is overall restricted when the osmolarity change is small and gradual, 2) other organic
osmolytes, such as creatine, myo-inositol, sorbitol, Nacetyl aspartate, phosphocreatine and phosphoethanol
amine, are also contributing to counteract the external
osmolarity, and altogether compensate for the initial
phase of hyposmotic stress, 3) a Cl- efflux activates, accompanied by cations other than K+, 4) rapid metabolic
changes such as synthesis of macromolecules, i.e. glycogen, may contribute to reduce the intracellular
osmolyte pool necessary to reach the osmotic equilibrium [74]. In more integrated preparations, such as the
hippocampal slice, it may happen that swelling occurs
in some but not in all cells, and therefore, the decrease
in amino acids and other osmolytes is required to compensate the change in cell volume only in a minor population of cells. Also, a redistribution of osmolyte amino
acids between different types of cells i.e. neurons and
astrocytes may occur, as observed in mice cerebellum
where taurine is translocated from Purkinje cells to astrocytes in response to hyponatremia [75]. In this situation, even though amino acids contribute importantly to
regulate cell volume in specific types of cells, this may
not result in a large net efflux. Finally, it should be no-
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Fig. 2. Amino acid release
from hippocampal slices exposed to gradual and
progessive reductions in external osmolarity. Slices
preloaded with [3H]-taurine
(●), D-[3H]aspartate (■), or
[3H]GABA (▲), were superfused 10 min with isosmotic
medium. At the time pointed
by the arrow the external osmolarity was continuosly decreased at a rate of –2.5
mOsm/min until the medium
osmolarity reached 150
mOsm (50% hyposmotic).
Data are expresed as efflux
rate constant (min-1) and are
means ± SE (n = 8-10).

ticed that in pathological situations, such as chronic hyponatremia, when the external osmolarity decrease is
small but persists during several hours, or even days, the
decrease in amino acids and other osmolytes during this
period is substantial, being almost 90% in the case of
taurine [2]. This has been reproduced in vitro by Olson
[76] in cultured astrocytes, which showed no change in
cell volume after 24 h of hyposmolarity, coincident with
an almost total depletion of the taurine pool, and no significant changes in the concentration of glutamate and
K+. This points to the role played by taurine as an
osmolyte of choice for cell volume control in physiopathological conditions.
The similarities or differences, which may exist
between the amino acid osmolyte pathway activated during IVR and RVD, have not been explored in detail. There
is also no information about transduction signalling cas-

cades leading to activation of this mechanism of cell
volume control. In this respect, it is worthy to mention
that IVR may be a better system than RVD for the study
of signalling cascades primarily associated with
osmotransduction. In the absence of the dramatic changes
in cell volume occurring during RVD, changes associated with cytoskeleton reorganization, adhesion and even
stress, would be reduced and consequently, the remaining set of signals expressed during IVR may be more
easily adscribed to specific aspects of cell volume regulation.
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